Changes in potential pathogenicity-associated proteins of Helicobacter cinaedi upon infection of macrophage cells

巨噬细胞感染后,幽门螺杆菌潜在致病相关蛋白的变化

阅读:4
作者:A K Voronina,B A Efimov,M V Malakhova,P V Shnaider,O M Ivanova,M Bogomiakova,V O Shender,M A Lagarkova,G P Arapidi

Abstract

Introduction: Helicobacter cinaedi is a spiral-shaped Gram-negative, enterohepatic bacterium classified as a conditional pathogen (pathogenicity group 2). It is known to cause bacteremia and a variety of other diseases in humans. In particular, Helicobacter cinaedi has been shown to impair intracellular cholesterol metabolism when interacting with macrophages, leading to foam cell formation. M1-macrophages transformed into the foam cell phenotype contribute to atherosclerotic plaques, suggesting a potential link between H. cinaedi infection and atherosclerosis development. Methods: To uncover protein factors involved in H. cinaedi pathogenesis, we performed a detailed mass spectrometric analysis of the proteome of strain BAA-847. This study represents the first comprehensive analysis of the bacterium's proteome under standard culture conditions and after infection of M1-type macrophage cells. Results: We identified 1,575 proteins in the H. cinaedi proteome, 109 of which were differentially upregulated after macrophage infection. Functional analysis revealed roles for these proteins in immune evasion, intracellular survival, and potential pathogenicity. Beyond known virulence factors (HcaA, Cdt, AhpC), we identified poorly characterized proteins with toxic or immunomodulatory functions. Notably, some upregulated proteins enable cholesterol utilization as a carbon source, while others may participate in a toxin injection mechanism disrupting host cell metabolism-potentially linked to foam cell formation. Conclusion: Our findings provide new insights into H. cinaedi pathogenicity, highlighting previously unexplored virulence mechanisms. The identified proteins could serve as targets for further research into H. cinaedi-associated diseases, including atherosclerosis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。